What is Travere Therapeutics, Inc.'s income tax?

Travere Therapeutics, Inc. (TVTX) reported income tax of -$120K in Q1 2026.

How has Travere Therapeutics, Inc.'s income tax changed year-over-year?

Travere Therapeutics, Inc.'s income tax decreased by 407.7% year-over-year, from $39K to -$120K.

What is the long-term trend for Travere Therapeutics, Inc.'s income tax?

Over 3 years (2021 to 2025), Travere Therapeutics, Inc.'s income tax has grown at a 34.2% compound annual growth rate (CAGR), from $409K to $988K.

What does income tax mean?

Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Travere Therapeutics, Inc. TVTX Income Tax

Income Tax at other companies

Vertex PharmaceuticalsVRTX

$221.5M+163%

LQD

Liquidia CorporationLQDA

$3.92M—

Arrowhead ResearchARWR

$7K-99.6%

PTC TherapeuticsPTCT

$347K-99.5%

Protagonist TherapeuticsPTGX

-$1.5M—

United TherapeuticsUTHR

$43.4M-57.2%

Segments

By segment

See full

Reportable Segment-$120K-408%

Other financials

Income statement

See full

Revenue$127.2M+55.6%

Gross profit$125.2M+62.5%

Operating income-$36.9M+13.5%

Net income-$37.1M+10.0%

EPS (diluted)-$0.40+14.9%

Balance sheet

See full

Cash & equivalents$78.4M+26.6%

Total debt$15.6M-82.6%

Total equity$98.7M+201%

Total assets$555.2M+1.2%

Cash flow

See full

Operating cash flow-$40.4M+4.3%

CapEx$140.0K—

Free cash flow-$42.5M+28.1%

Valuation

See full

Market cap$5.13B+72.3%

Enterprise value$5.07B+65.5%

P/S9.6×-1.3×

Profitability

See full

Gross margin98.6%+2.6pp

Operating margin-10.6%-5.0pp

Net margin-20.3%-9.5pp

FCF margin-133.9%-34.4pp

Returns & leverage

See full

Return on equity-706%-1,302pp

Debt / equity0.2×-2.6×

Current ratio3.1×+1.1×

Where this comes from

Reported directly by Travere Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s income tax?: Travere Therapeutics, Inc. (TVTX) reported income tax of -$120K in Q1 2026.
How has Travere Therapeutics, Inc.'s income tax changed year-over-year?: Travere Therapeutics, Inc.'s income tax decreased by 407.7% year-over-year, from $39K to -$120K.
What is the long-term trend for Travere Therapeutics, Inc.'s income tax?: Over 3 years (2021 to 2025), Travere Therapeutics, Inc.'s income tax has grown at a 34.2% compound annual growth rate (CAGR), from $409K to $988K.
What does income tax mean?: Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.